Dr. Deepa Sashital, MD
What this data tells you about Dr. Sashital
Dr. Deepa Sashital is a hematology & oncology in Baytown, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sashital performed 44,820 Medicare services across 1,358 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sashital received a total of $8,728 from 41 pharmaceutical and/or device companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sashital is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 18,000 | $0 | $2 |
| Iron infusion (Feraheme) | 10,710 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 7,000 | $38 | $136 |
| Anti-nausea injection (fosaprepitant) | 4,350 | $0 | $5 |
| Blood draw (venipuncture) | 815 | $8 | $20 |
| Dexamethasone injection (steroid) | 802 | $0 | $1 |
| Complete blood count (CBC) with differential | 724 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $114 |
| Office visit, established patient (30-39 min) | 324 | $95 | $368 |
| Office visit, established patient (20-29 min) | 162 | $64 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 149 | $20 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 142 | $48 | $313 |
| Administration of chemotherapy into vein, 1 hour or less | 136 | $94 | $707 |
| Drug injection, under skin or into muscle | 128 | $10 | $96 |
| Reticulated (young) platelet measurement | 95 | $35 | $143 |
| Injection, zoledronic acid, 1 mg | 85 | $7 | $431 |
| Microscopic examination for white blood cells with manual cell count | 70 | $4 | $22 |
| Complete blood count (CBC), automated | 70 | $6 | $34 |
| Administration of additional new drug or substance into vein, 1 hour or less | 70 | $40 | $344 |
| Injection of additional new drug or substance into vein | 69 | $10 | $108 |
| Office visit, established patient, complex (40-54 min) | 69 | $137 | $496 |
| Injection, diphenhydramine hcl, up to 50 mg | 62 | $1 | $7 |
| Hospital follow-up visit, low complexity | 47 | $40 | $135 |
| Initial hospital admission, moderate complexity | 43 | $103 | $470 |
| Hospital follow-up visit, moderate complexity | 43 | $64 | $247 |
| New patient office visit (45-59 min) | 42 | $114 | $565 |
| Unclassified drugs | 37 | $1 | $8 |
| Hospital follow-up visit, high complexity | 25 | $96 | $357 |
| Stool analysis for blood to screen for colon tumors | 17 | $4 | $24 |
| Initial hospital admission, high complexity | 17 | $140 | $694 |
| New patient office visit (30-44 min) | 15 | $80 | $372 |
| Red blood count, automated test | 12 | $4 | $23 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sashital is a mixed practice specialist, with above-average Medicare volume (top 21% in TX), and consulting-driven industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sashital experienced with iron sucrose injection (venofer)?
Does Dr. Sashital receive payments from pharmaceutical companies?
How do Dr. Sashital's costs compare to other hematology & oncologys in Baytown?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology